STERIS plc STE
256.94 USD +4.64 (+1.84%)
At closeNov 10, 2026, 4:01 AM EST
259.20 +2.26 +0.88%
Pre-market · Nov 10, 4:01 AM ET
249.67 Day range 259.09
195.14 52-week range 269.44
- YTD
- +1.35%
- 1 year
- -2.59%
News
marketbeat.com What STERIS (STE) Said on Its Q2 Earnings Call STERIS NYSE: STE raised its fiscal 2027 earnings outlook after reporting higher second-quarter revenue and profit, as tariff refunds helped expand margins and strong Life Sciences equipment shipments…
benzinga.com Keybanc Maintains Overweight on Steris, Raises Price Target to $284 Keybanc analyst Brett Fishbin maintains Steris (NYSE:STE) with a Overweight and raises the price target from $269 to $284.
zacks.com STE Stock Up on Q2 Earnings & Revenue Beat, '27 EPS View Up STERIS beats Q2 fiscal 2027 earnings and revenue estimates, fueled by strong segment growth and margin gains, and raises its full-year adjusted EPS outlook.
benzinga.com Steris Q2 2027 Earnings Call Transcript Steris (NYSE:STE) reported second-quarter financial results on Thursday. The transcript from the company’s second-quarter earnings call has been provided below.This transcript is brought to you by…
zacks.com Compared to Estimates, Steris (STE) Q2 Earnings: A Look at Key Metrics Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall…
zacks.com Steris (STE) Q2 Earnings and Revenues Surpass Estimates Steris (STE) came out with quarterly earnings of $2.94 per share, beating the Zacks Consensus Estimate of $2.67 per share. This compares to earnings of $2.47 per share a year ago.
benzinga.com Steris Raises FY2027 Adj EPS Guidance from $11.00-$11.30 to $11.35-$11.55 vs $11.18 Est; Lowers FY2027 Sales Guidance of $6.352B-$6.411B vs $6.373B Est Steris (NYSE:STE) raises FY2027 Adj EPS guidance from $11.00-$11.30 to $11.35-$11.55 vs $11.18 analyst estimate. Lowers FY2027 sales outlook from $6.352 billion-$6.411 billion to $6.352…
benzinga.com Steris Q2 Adj. EPS $2.94 Beats $2.68 Estimate, Sales $1.589B Beat $1.562B Estimate Steris (NYSE:STE) reported quarterly earnings of $2.94 per share which beat the analyst consensus estimate of $2.68 by 9.7 percent. This is a 19.03 percent increase over earnings of $2.47 per share…
globenewswire.com STERIS Announces Financial Results for Fiscal 2027 Second Quarter DUBLIN, IRELAND, Nov. 04, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2027 second quarter ended September 30, 2026.…
benzinga.com STERIS Inks Deal To Acquire Xodus Medical For $2.1B STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced that STERIS Corporation, a wholly owned subsidiary of the Company, has signed a definitive agreement to acquire Xodus Medical, Inc.,…
sports.yahoo.com Three weeks in the making: Drew Mestemaker finally gets his wish on Oklahoma State trick play Drew Mestemaker waited three weeks for Oklahoma State to call a trick play designed to get him a touchdown reception. Against Kansas State, Wyatt Young finally delivered, helping the quarterback make…- finance.yahoo.com Celebrate America Recycles Day: Cirba Solutions Invites Greater Phoenix Community to Recycle Batteries for Free on Nov. 12 In recognition of America Recycles Day, Cirba Solutions, a leading battery recycling and critical mineral recovery company, is making it easier to safely and responsibly recycle end-of-life batteries.
finance.yahoo.com North Texas Roofing Marks 10,000+ Roofing Projects Completed, Reinforcing Its Reputation as a Trusted Roofing Contractor in Keller, TX The family-owned Keller company has operated since 1999 and holds an A+ rating from the Better Business Bureau, serving Kelly ...
marketwatch.com Steris PLC stock rises Monday, still underperforms market Steris PLC closed 4.64% below its 52-week high of $269.44, which the company reached on January 16th. Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated…
msn.com 73 stocking stuffers both kids and adults will love Small treasures for the young and young at heart.
financialcontent.com Investor Alert: Robbins LLP Informs Investors of the CVRx, Inc. Class Action Lawsuit The complaint alleges that CVRx misled investors regarding misconduct that exposed the Company to liability under the False Claims Act and Anti-Kickback Statute. Investors who purchased CVRx, Inc.msn.com Australia once had 1,100-pound demon ducks that stood over 10 feet tall Australia was once home to enormous flightless birds that stood over 10 feet tall and weighed more than half a ton. This ...
msn.com New York Jets finally land their franchise QB, his new best friend, and a defensive makeover in 7-round 2027 NFL mock draft New York Jets land an insane haul during the latest 7-round 2027 NFL mock draft. It sets the organization up for great future ...
- theglobeandmail.com DAVA Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Class Action Lawsuit Against Endava plc November 9, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Endava plc (NYSE:…
theglobeandmail.com AVXL Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Class Action Lawsuit Against Anavex Life Sciences Corp. Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Anavex Life Sciences Corp. (NASDAQ: AVXL)…